Charvat J C, Brutsche M, Frey J G, Tschopp J M
Centre valaisan de Pneumologie, Montana.
Praxis (Bern 1994). 1998 Mar 4;87(10):336-40.
Malignant pleural mesothelioma (MPM) remains a disease of very poor prognosis despite all new therapeutic approaches. We describe here 13 cases with MPM. The main symptoms at presentation were dyspnea (12/13) followed by weight loss (7/13), cough (3/13) and thoracic pain (2/13). On chest X-ray, all patients had pleural effusion associated with pleural thickening in 8/13 cases (62%). A definitive diagnosis was brought by thoracoscopy in 11/12 cases (diagnostic sensitivity 92%). In one patient, thoracoscopy was technically impracticable because of very important obesity. By thoracoscopic talc pleurodesis, we were able to control the pleural effusion in all patients with suppression of dyspnea (11). The mean survival after diagnosis was 6.8 +/- 5.0 months (range 1-16). At the present time, we believe that thoracoscopy is well indicated in any suspicion of MPM not only for diagnosis but also for palliative treatment of this pleural disease. However, there is a need for well controlled studies to improve the outcome of MPM.
尽管有各种新的治疗方法,但恶性胸膜间皮瘤(MPM)仍然是一种预后很差的疾病。我们在此描述13例MPM患者。就诊时的主要症状为呼吸困难(12/13),其次是体重减轻(7/13)、咳嗽(3/13)和胸痛(2/13)。胸部X线检查显示,所有患者均有胸腔积液,其中8/13例(62%)伴有胸膜增厚。11/12例患者通过胸腔镜检查确诊(诊断敏感性为92%)。有1例患者因过度肥胖,胸腔镜检查在技术上不可行。通过胸腔镜滑石粉胸膜固定术,我们成功控制了所有患者的胸腔积液,缓解了呼吸困难(11例)。确诊后的平均生存期为6.8±5.0个月(范围1 - 16个月)。目前,我们认为对于任何怀疑MPM的患者,胸腔镜检查不仅适用于诊断,也适用于这种胸膜疾病的姑息治疗。然而,需要进行严格对照研究以改善MPM的治疗效果。